Friday, June 17, 2011

Funding for new mental health and dementia drugs dries up

Following is a snippet from an article in the journal "Nature" regarding funding for new mental health drugs.  Click on the link to read the entire article--it's surprisingly easy to understand and scary.

Psychopharmacology in crisis

Researchers warn of 'withdrawal of hope' as funding shrivels.
Patients face a "withdrawal of hope" as neuropsychopharmacology funding falters.SOVEREIGN, ISM/SCIENCE PHOTO LIBRARY
Many people affected by mental illness are facing a bleak future as drug companies abandon research into the area and other funding providers fail to take up the slack, according to a new report.
Produced for the European College of Neuropsychopharmacology (ECNP), the report warns that "research in new treatments for brain disorders is under threat". With current treatments inadequate for many patients, it says, "withdrawal of research resources is a withdrawal of hope for patients and their families"1.

Here is the link to the entire article....

I always comfort myself, when I look at my mom and wonder if that's my destiny, too, by telling myself "well, if it is, the treatments will be much better by then...."  so this article was an unwelcome eye-opener.